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Neurovascular functions, including cerebral blood flow 
(CBF) and blood-brain-barrier (BBB) function, play an 
important role on determining cognitive capability and 
mental health [1]. Studies have shown that 
neurovascular risk is highly associated with accelerated 
decline in language ability, verbal memory, attention 
and visuospatial abilities [2, 3]. Reduced CBF is linked 
to anxiety and depression [4-6], and impaired BBB is 
associated with neuroinflammation and synaptic 
dysfunction [7]. These neurovascular deficits are 
exacerbated   with  age   [8]   and  in  a  more  rapid  and  
 
profound fashion in neurodegenerative disorders, 
including Alzheimer’s disease (AD) [9-12]. 
Interventions that are able to maintain neurovascular 
integrity are thus considered crucial for impeding age-
related neurological disorders. 
 
Caloric restriction (CR), without malnutrition, is the 
most studied intervention that has been shown to extend 
the longevity of a broad range of species [13-15]. In the 
central nervous system, CR has also been shown to 
induce anti-inflammatory mechanism, reduce oxidative 
stress and promote synaptic plasticity [16]. In aging, CR 
protects mitochondrial function, neuronal activity, brain 






















Neurovascular  integrity plays an  important  role  in protecting  cognitive and mental health  in aging.  Lifestyle




blood‐brain  barrier  function  in  young mice  at  5‐6 months  of  age.  The  neurovascular  enhancements  were
associated with reduced mammalian target of rapamycin expression, elevated endothelial nitric oxide synthase






www.aging‐us.com  2815  AGING (Albany NY) 
volume size and white matter integrity [14, 17, 18]. 
Enhanced memory in elderly humans and aging animals 
has also been reported with CR [19-22]. In animal 
models of AD, CR reduces amyloid beta (Aβ) 
deposition and preserves memory [23, 24]. However, 
the impact of CR on CBF and BBB, and the interplay 
between in vivo neurovascular functions, cognitive 
aging, and mental health, remain unknown. 
 
In this study, our primary goal was to identify age-related 
changes of neurovascular integrity in response to CR. We 
previously showed that CR is protective for CBF in old 
adult rodents [25]. Here we further determined whether 
CR shows early effects on neurovascular functions, and 
the potential changes in vascular signaling markers 
thereof, in young adult animals. Our secondary goal was 
to determine the correlation between neurovascular 
function, cognitive integrity, and mental health across the 
young and old mice. We hypothesized that CR has 
significantly protective effects on CBF and BBB, which 
may contribute to preserved neurovascular integrity, 
learning and memory, and reduced anxiety in aging. We 
used magnetic resonance imaging (MRI) to quantify in 
vivo CBF and confocal imaging to measure BBB 
function, and biochemical assays to determine 































used to assess cognition, anxiety of the mice, and the 
correlation between behavioral and neurovascular 
outcomes. The findings from this study will enhance our 
understanding regarding the effectiveness of nutritional 




Caloric restriction enhances neurovascular 
functions in young mice 
 
We firstly determined the CBF and BBB changes in 
response to CR in young adult mice (5-6 months of 
age). We used MRI to measure CBF in mice fed with 
either ad libitum (AL) or 40% CR (N = 12 per group). 
Fig. 1A shows the group-averaged CBF images of AL 
and CR mice. The CBF level is colorized in a linear 
scale, indicating that CR mice have overall higher CBF 
compared to the AL mice. We did further CBF analyses 
in brain regions associated with cognitive functions 
(e.g., memory and learning) based on MRI structural 
imaging and mouse brain atlas. We found that young 
CR mice had significantly higher CBF in frontal cortex 
(p < 0.01; Fig. 1B) and hippocampus (p < 0.01, Fig. 
































brain  images;  the  color  code  indicates  the  level of CBF  in a  linear  scale. Quantitative CBF  (ml/g/min) obtained  from  (B) Frontal
Cortex and (C) Hippocampus. (D) Representative confocal images showing increased luminal accumulation of NBD‐CSA fluorescence
(green)  in brain  capillaries  isolated  from  young CR mice;  shown  in arbitrary  fluorescence units  (scale 0‐255).  (E) Corresponding
quantitative  fluorescence data. Data are mean ± SEM. **p < 0.01; ***p < 0.001; n.s.: non‐significant; AL: ad  libitum; CR: caloric
i i






























BBB function was determined by measuring P-
glycoprotein (P-gp) transport activity from cortical 
capillaries. P-gp is an ATP-driven transporter highly 
expressed at the BBB that facilitates clearance of Aβ, a 
hallmark of AD. We previously established a confocal 
imaging-based assay to assess P-gp transport activity in 
freshly isolated brain capillaries from mice [26, 27]. 
This assay measures within capillary lumens 
accumulation of [N-ε(4-nitro-benzofurazan-7-yl)-D-
Lys(8)]-cyclosporin A (NBD-CSA), a fluorescent P-
glycoprotein substrate. Fig. 1D shows representative 
confocal images of capillaries incubated to steady state 
in medium containing 2 µM NBD-CSA; the intensity of 
fluorescence in the capillary lumen reflects the amount 
of NBD-CSA transported by P-gp. The corresponding 
quantitative results are shown in Fig. 1E. Young CR 
mice had enhanced P-gp transport activity (2.4 fold 
increase; p < 0.0001) compared to AL mice.  
 
Caloric restriction enhances vascular signaling 
markers and shifts metabolism in young mice 
 
Caloric restriction has been shown to inhibit mammalian 
target of rapamycin (mTOR), a nutrient sensor, in 
response to cellular energy status and growth factors [28, 
29]. We and others have previously showed that 






























oxide synthase (eNOS) and releases nitric oxide, a 
vasodilator, which in turn causes increased CBF [30, 
31]. To determine whether the enhancement of 
neurovascular functions in the young adult mice is also 
associated with mTOR signaling, we measured the 
protein levels of mTOR and eNOS in capillaries 
isolated from young CR and AL mice (Fig. 2A). We 
found that, compared to AL mice, CR mice had 
significantly lower level of mTOR (decrease to 71.1 ± 
1% over 100% controls; p < 0.01; Fig. 2B), but higher 
level of eNOS (increase by 146.5 ± 11.6% over 100% 
controls; p < 0.001; Fig. 2C), consistent with our 
previous findings [30]. We also measured P-gp protein 
expression levels (Fig. 2A). Similar to the results of P-
gp activity, we found that CR mice had significant 
enhancement in P-gp protein levels compared to the AL 
mice (increase by 168.4 ± 23.1% over 100% controls; p 
< 0.001; Fig. 2D). 
 
Reduced mTOR also implies metabolic status changes, 
we thus measured levels of the glucose transporter 1 
(GLUT1) using Western blot (Fig. 2A). We observed a 
significant decrease of GLUT1 in young CR mice 
compared to the young AL mice (decrease to 70.9 ± 
7.5% over 100% controls; p < 0.01; Fig. 2E). This is 
consistent with blood glucose results, showing that CR 
mice had significantly reduced blood glucose levels 
Figure 2. Caloric restriction enriches vascular signaling markers and shifts metabolism in young mice.
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relative to the AL mice (p < 0.01; Fig. 2F). In contrast, 
CR mice had significantly higher levels of blood ketone 
bodies compared to the AL mice (p < 0.05, Fig. 2G). 
This is consistent with our previous findings that caloric 
restriction shifts metabolism from glucose to ketone 
bodies utilization [17, 25]. 
 
Caloric restriction decelerates the rate of decline of 
cerebral blood flow in aging mice 
 
We further determined the CBF and BBB function 
changes in response to CR in old adult mice (18-20 
months of age; 12 AL and 12 CR mice). Similar to the 
findings in the young mice, we found that old CR mice 
had significantly higher CBF compared to the old AL 
mice, both in the frontal cortex (p < 0.01; Fig. 3A) and 
hippocampus (p < 0.01, Fig. 3B). However, we did not 
observe a difference in P-gp activity between the two 
groups (p > 0.05, Fig. 3C).  
 
We calculated the age-related changes in CBF and BBB 
function. We found that in the frontal cortex, old AL 
mice had 43.13% group averaged decline of CBF 
compared to the young AL mice (no variation was 
available due to cross-sectional comparison); In 
contrast, the old CR mice had only 22.28% averaged 






























Similar pattern was found in hippocampus – old AL 
mice had 45.10% averaged decreases in CBF, whereas 
old CR mice had 28.13% averaged reduction, compared 
to their young littermates (Fig. 3E). On the other hand, 
we found that there was a higher reduction rate of P-gp 
activity in the CR group (-75.33%) compared with the 
AL group (-45.45%; Fig. 3F). Collectively, we found 
that caloric restriction impeded the age-dependent 
decline of CBF but not P-gp activity (BBB function). 
 
Caloric restriction preserves learning and long-term 
memory of aging mice 
 
We used radial arm water maze (RAWM) to evaluate 
learning and spatial memory of the mice [32, 33]. Fig. 
4A illustrates the RAWM assessment. The task for the 
mice was to identify the arm which contains a hidden 
platform. Wrong entries of the arms were recorded as 
errors. The protocol consisted of a two-day testing 
paradigm. Day 1 was the “learning” phase where mice 
went through three blocks (Blocks 1-3; 5 trials in each 
block) to test learning and short-term spatial memory. 
Day 2 was the “recall” phase where mice went through 
three additional blocks (Blocks 4-6) to test long-term 
memory after a 24-hour retention period to locate the 
platform. It is expected that after the two-day training, 






























Figure  3.  Caloric  restriction  decelerates  the  rate  of  decline  of  cerebral  blood  flow  in  aging mice. Old  CR mice  had
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with minimal errors. In young mice, we saw no 
significant difference between AL and CR groups (Fig. 
4B). In old mice, however, AL group made significantly 
more errors in the initial learning phase (Block 1; p < 
0.01) and the initial recall phase (Block 4; p < 0.01), 
compared to the CR group (Fig. 4C). In addition, we 
found that old CR had similar performances in both 
Block 1 (Fig. 4D; p > 0.05) and Block 4 (Fig. 4E; p > 
0.05) compared to the young mice (both AL and CR), 
suggesting that old CR mice had preserved learning and 
long-term memory abilities. 
 
We used combined errors from Blocks 1 and 4 to further 
identify the correlation between cognitive function and 
CBF. We found that the errors made in RAWM had 
significantly inverse correlations with hippocampal CBF 
(r2 = 0.29, p < 0.001; Fig. 4F) and frontal CBF (r2 = 0.27, 
p < 0.001; Fig. 4G), indicating that level of CBF in 
cognition-associated brain regions is highly associated 
with learning and spatial memory performances.  
 
Caloric restriction reduces anxiety of aging mice 
 
We used elevated plus maze (EPM) to evaluate anxiety 































open and two closed arms. Closed arms are perceived as 
safe zones, and thus mice with higher anxiety had 
tendency to stay in the closed arms. We determined the 
anxiety-related behavior by measuring the time spent in 
the closed arms over the 5 min. test session. For the 
young mice, we did not find significant differences 
between the CR and AL groups (p > 0.05; Fig. 5B), 
though CR mice had a trend of less time in the closed 
arms. In contrast, old AL mice spent significantly 
longer time in the closed arms compared to the old CR 
mice (p < 0.01; Fig. 5C), indicating higher anxiety of 
the old AL mice. Consequently, when comparing the 
age-related performances, the AL group showed higher 
increases in anxiety (31.43% group averaged) compared 
to the CR mice (12.54% group averaged) (Fig. 5D). We 
also found it had significant and inverse correlations 
between closed arm duration and CBF in hippocampus 
(r2 = 0.40, p < 0.0001; Fig. 5E) and in frontal cortex (r2 




To our knowledge, this is the first study to investigate 
the interplay between CR-induced changes of 
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health in aging using neuroimaging, behavioral 
assessments, and biochemical assays. In this study, we 
demonstrate (i) in young mice, CR enhanced CBF and 
BBB function, (ii) inhibited mTOR, which was 
associated with increased eNOS, reduced glucose 
metabolism, and increased blood ketone level; (iii) in 
the aging mice, CR preserved CBF, learning, long-term 
memory, and reduced anxiety; (iv) hippocampal and 
frontal CBF exhibited high association with cognitive 
performance and inversely correlated with anxiety level. 
 
Our results indicate that young CR mice had significant 
enhancement of CBF and BBB function, which in turn 
may be associated with mTOR signaling changes 
induced by CR. In addition to modulating eNOS, we 
previously demonstrated that mTOR inhibition reduces 
proinflammatory cytokine that breaks down BBB, and 
thus restores BBB integrity and CBF in mice that 
carries human APOE4 gene [35]. Furthermore, mTOR 
is able to clean up misfolded proteins (such as Aβ and 
cerebral amyloid angiopathy) via regulation of 
autophagy [36], therefore, it can further reduce athero-
sclerosis and preserve neurovascular integrity, e.g., 
vascular density [30]. mTOR signaling also integrates 































works with insulin/insulin-like growth factors and 
serotonin, to exert beneficial effects on vascular system 
by decreasing blood pressure, atherogenic lipids, 
inflammatory cytokines and oxidative stress, and 
increased cellular stress resistance [37, 38]. As shown in 
the present and previous studies, mTOR inhibition leads 
to metabolic shift from utilizing carbohydrate (e.g., 
glucose) to fatty acid (e.g., ketone bodies produced 
from fatty acids) [17, 25, 39, 40]. Increased levels of 
ketone bodies have shown to evoke CBF response, and 
reduce oxidative stress, neuroinflammation and Aβ [39, 
41-44]. 
 
Increased CBF and ketone bodies metabolism suggest 
increased oxidative metabolism within the brain of 
young mice. Basal CBF is tightly coupled with cerebral 
metabolic rate of oxygen [45] and utilization of ketone 
bodies significantly elevate the oxygen utilization in 
mitochondria through beta-oxidation of fatty acid [40, 
46]. This is supported by evidence from isolated 
mitochondria, showing CR enhances mitochondrial 
function and induces bioenergetic efficiency (7,19). 
This is also consistent with our previous imaging 
findings that old animals with chronic CR diet had pre-



































mice,  and  (C) Old AL  and CR mice.  (D)  The  age‐dependent  changes of  anxiety  level between AL  and CR mice.  Significant  inverse
correlation between closed arm duration and CBF  in  (E) hippocampus  (r2 = 0.40, p < 0.0001) and  (F)  frontal cortex  (r2 = 0.39, p <
0.0001). Color codes indicate the four groups of mice. Data are mean ± SEM. **p < 0.01; AL: ad libitum; CR: caloric restriction. 
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(TCA cycle flux and ATP production), and neuronal 
activity (neurotransmission rate) compared to the old 
AL animals [18]. The increased oxidative metabolism, 
particularly in brain regions associated with cognition 
(e.g., frontal cortex and hippocampus), may also play a 
crucial role for neuronal and cognitive protections. 
Previous studies showed that cognition-associated brain 
regions have non-oxidative glycolysis exceeding the 
required needs of oxidative phosphorylation, a 
phenomenon known as aerobic glycolysis (AG) [47]. 
Excessive AG (or the "Warburg effect") is a key process 
that sustains T cell activation and differentiation and is 
involved in inflammatory-mediated conditions [48]. In 
line with this, the distribution of AG in normal young 
adults is spatially correlated with Aβ deposition in AD 
patients and cognitively normal individuals with 
elevated Aβ [49, 50]. Animal studies further 
demonstrated that Aβ plaque formation is an activity 
dependent process associated with AG [49, 51]. 
Therefore, increased oxidative metabolism in cognition-
related regions may decrease AG and thus reduce the 
risk for AD, consistent with the findings in CR mice 
[23, 24].  
 
The early-life neurovascular and neurometabolic 
changes may play a critical role in protecting 
physiological functionality and enhancing cognitive 
reserve with age [52]. Recent studies reported that 
lifestyle factors act as moderators for cognitive reserve 
to protect against AD in the elderly [52, 53]. The study 
suggested that neuroprotective mechanisms play a 
major role during early stages and compensatory 
mechanisms in later stages of the disease. In line with 
this, we observed that the CR mice had a slower 
reduction rate in CBF with age compared with the AL 
mice. As a result, the old CR mice had comparable 
levels of CBF compared to the young AL mice, similar 
to our previous findings in rats [25]. The preservation of 
hippocampal and frontal CBF were associated with 
improved cognition in the old CR mice. This is also 
consistent with our previous findings that restoration of 
CBF in young mice modeling human AD could 
potentially prevent their cognitive decline in aging [30, 
35].  
 
We further identified that CR reduced anxiety levels in 
aging mice. Similar findings were reported in a recent 
study, showing rhesus monkeys on a 30% CR diet 
demonstrated less anxious behavior than controls in 
different arousing contexts [54]. These results are 
consistent with other studies, indicating that mTOR 
inhibition is playing an important role on anxiety- and 
depressive-like behaviors [55]. Treating mice with 
rapamycin, an mTOR inhibitor, Halloran et al. observed 
reduced anxiety-like behavior, e.g., reduced thigmotaxis 
(swimming in close proximity to the pool wall), in mice 
with AD-like pathology. They also found a reduction in 
depressive-like behavior in the mice, e.g., floating 
during training phase of the Morris water maze and 
reduced time spent immobile on the tail suspension test. 
Similar effects have been reported for genetically 
modified mice with autistic-like behavior, showing that 
mTOR inhibition attenuated anxiety, hyperexcitability, 
abnormal social interaction, repetitive behavior and 
vocalizations of the mice [56, 57]. It has been shown 
that the changes in anxiety- and depressive-like 
behavior were correlated with increased levels of 
dopamine and dopamine metabolites in the midbrain 
[55]. Our study found that CBF was highly correlated 
(inversely) with anxiety level, which is consistent with 
previous findings [4-6].  
 
We demonstrated that CR had beneficial effects on 
aging brain functions, potentially via the mTOR 
pathway. Genetic or pharmacological inhibition of 
mTOR signaling has shown to slow aging and extend 
lifespan in various species, and confer protection 
against many age-related pathologies [58]. Here we 
further show that activating the mTOR pathway could 
potentially protect brain function (both cognitive and 
non-cognitive types of behavior) in healthy aging by 
preserving neurovascular function. Specifically, mTOR 
inhibition was associated with increased eNOS, which 
may contribute to CBF enhancements in young CR 
mice and preservation in old CR mice. In AL mice 
(control), we found decreased P-gp protein expression 
and activity with age, which is consistent with previous 
literature findings in different mouse models [59-61]. In 
CR mice, however, calorie restriction did not preserve 
P-gp expression and activity with age. To this date it is 
unknown how blood-brain barrier P-gp activity is 
regulated in aging and how it can be preserved. Thus, 
more studies are needed to investigate potential 
signaling steps that lead to age-mediated reduction of P-
gp at the BBB. Future studies will also need to further 
investigate the potential mechanism of CR effects on 
BBB function with age.  
 
It has to be pointed out that we used a long-lived animal 
model (C57BL/6N) in the study. We recognize, 
however, that the CR effects may be strain- and 
genetics- dependent. Recent studies showed that CR had 
adversely impacted several inbred mice, including 
shortening lifespan and impairing fat storage with age 
[62, 63]. Therefore, it would be important for future 
studies to take into account genetic background to 
identify the effects of CR on brain aging. This is also 
applicable for humans, where each individual would 
have different responses to identical foods due to their 
genotype. Recent studies have shown that personalized 
diet could be prescribed based on the individual’s 
genetic response to post-meal blood sugar changes [64]. 
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Precision nutrition would be very useful in the future to 
slow down brain aging and to prevent AD, and the 
progress can be monitored by in vivo neuroimaging and 
cognitive testing. 
 
In conclusion, we used neuroimaging, behavioral 
assessments and biochemical assays to identify 
correlations between vascular integrity, cognitive 
functions, and mental health induced by CR in aging 
mice. We showed that neurovascular functions were 
enhanced in young CR mice, as well as preservation of 
CBF, cognition, and anxiety level in aging CR mice. 
Our study suggests that mTOR pathway may be 
critically involved in the process. These findings imply 
that dietary intervention started in the early stage (e.g., 
young adults) may benefit cognitive reserve in aging. 
Understanding nutritional effects on brain vascular, 
cognitive, and mental functions may have profound 
implications in human aging and other age-related 
neurodegenerative disorders. In the future, using in 
vivo MRI and cognitive assessments, we could be in 
a position to identify effective personalized 
nutritional interventions and treatment efficacy there-







We used male C57BL/6N mice in the study as they 
demonstrated extended longevity with CR [65, 66]. 
Young (5–6 months) and old (18-20 months) adult mice 
were obtained from the National Institute on Aging 
Caloric Restriction Colony. At the National Institute on 
Aging, all mice were fed ad libitum [National Institutes 
of Health (NIH)-31 diet] until 14 weeks of age. The CR 
regimen was initiated by incremental caloric reduction 
of 10% at week 14, 25% at week 15, and reaching full 
40% CR by week 16 with continuation of the diet over 
the lifetime. The vitamin-fortified NIH-31 (NIH-31 
fortified) diet fed to CR mice provided 60% of the 
calories and additional vitamins supplement consumed 
by ad libitum mice. After arriving at our facilities, mice 
were housed individually (1 mouse per cage) in a 
specific pathogen-free facility. We determined the 
sample size with power analysis in order to perform the 
comparison at a 0.05 level of significance, with a 90% 
chance of detecting a true difference of all the 
measurements between the four groups. Twelve mice 
per group were used in the study. All experimental 
procedures were approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of 
Kentucky (UK) and in compliance with the ARRIVE 
guidelines [67]. 
Cerebral blood flow measurement 
 
MRI experiments were performed on a 7T MR scanner 
(Clinscan, Bruker BioSpin, Germany) at the Magnetic 
Resonance Imaging & Spectroscopy Center of the 
University of Kentucky. Mice were anesthetized with 
4.0% isoflurane for induction and then maintained in a 
1.2% isoflurane and air mixture using a nose cone. 
Heart rate (90–110 bpm), respiration rate (50-80 
breaths/min), and rectal temperature (37 ± 1 °C) was 
continuously monitored and maintained. T2-weighted 
structural images were acquired with field of view 
(FOV) =18 x18 mm2, matrix = 256 x 256; slice 
thickness = 1 mm, 10 slices, repetition time (TR) = 
1500 ms, and echo time (TE) = 35 ms. Quantitative 
CBF (with units of mL/g per minute) was measured 
using MRI-based pseudo-continuous arterial spin 
labeling (pCASL) techniques. A whole body volume 
coil was used for transmission and a mouse brain 
surface coil was placed on top of the head for receiving. 
Paired control and label images were acquired in an 
interleaved fashion with a train of Hanning window-
shaped radiofrequency pulses of duration/spacing = 
200/200 μs, flip angle = 25° and slice-selective gradient 
= 9 mT/m, and a labeling duration = 2100 ms [68]. The 
images were acquired by 2D multi-slice spin-echo echo 
planner imaging with FOV =18 x18 mm2, matrix =128 
x 128, slice thickness = 1 mm, 10 slices, TR = 4,000 
ms, TE = 35 ms, and 120 repetitions. pCASL image 
analysis was employed with in-house written codes in 
MATLAB (MathWorks, Natick, MA) to obtain 
quantitative CBF [69]. 
 
Radial arm water maze 
 
As shown in Fig. 3A, the RAWM task can be used to 
measure both spatial working memory and spatial 
reference memory [32, 33]. The RAWM task was 
conducted in the Rodent Behavioral Core (RBC) of UK 
as described previously [17], following a 2-day testing 
paradigm. A staggered training schedule was used, 
running the mice in cohorts of ten mice, while 
alternating the different cohorts through the trials over 
day 1 and day 2 of the test. This alternating protocol 
was used to avoid the learning limitations imposed by 
massed sequential trials and to avoid fatigue that may 
result from consecutive trials. Geometric extra-maze 
visual cues were fixed throughout the study on three 
sides of the curtains. Visual platform trials were 
included in the training, and were used to determine if 
visual impairment could be a cofounding variable. The 
mouse performance was recorded by EthoVision XT 8.0 
video tracking software (Noldus Information 
Technology). Data were analyzed by the EthoVision 
software for the number of incorrect arm entries, which 
are defined as errors. The video was reviewed for each 
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mouse to ensure that the mice did not employ nonspatial 
strategies, such as chaining, to solve the task. 
 
Elevated plus maze 
 
The EPM was also performed at RBC of UK. The maze 
consists of four arms (two enclosed arms and two open 
arms) elevated 100 cm above the floor (Fig. 5A). The 
time that mouse spent in the closed arms and open arms 
of the maze were recorded automatically over the 5 min 
test session by EthoVision XT 8.0 video tracking 
software (Noldus Information Technology). 
 




Brain capillaries were isolated from mice according to a 
previously described protocol [26, 70]. Briefly, mice 
were euthanized by CO2 inhalation and decapitated; 
brains were immediately harvested and collected in ice-
cold DPBS buffer supplemented with 5 mM D-glucose 
and 1 mM Na-pyruvate, pH 7.4. Brains were dissected 
by removing meninges, choroid plexus and white 
matter, and homogenized in DPBS. The brain 
homogenate was mixed with Ficoll® and centrifuged at 
5,800g for 20 min at 4°C. The capillary pellet was 
resuspended in 1% BSA buffer and first passed through 
a 300 µm nylon mesh and then through a 27 µm nylon 
mesh. Capillaries retained by the 27 µm nylon mesh 
were collected and washed with DPBS buffer, and used 
for experiments. 
 
P-glycoprotein transport activity 
Isolated capillaries were incubated for 1 h at room 
temperature with 2 μM NBD-CSA (custom-synthesized 
by R. Wenger (Basel, Switzerland)) in DPBS buffer. 
Ten capillary images were acquired by confocal 
microscopy (Leica TSP SP5 Confocal Microscope with 
Environmental Chamber, 63 × D-Water UV objective, 
numerical aperture 1.2, 488-nm line of an argon laser, 
Leica Microsystems). Confocal images were analyzed 
by quantitating luminal NBD-CSA fluorescence with 
Image J software (v.1.45s; Wayne Rasband, NIH). 
Specific, luminal NBD-CSA fluorescence was taken as 
the difference between total luminal fluorescence and 
fluorescence in the presence of the P-glycoprotein-
specific inhibitor PSC833 (5 μM, Novartis, Basel, 
Switzerland) [71]. 
 
Western blotting and quantification 
To determine protein expression, isolated brain 
capillaries were homogenized in tissue lysis buffer 
containing protease inhibitor cocktail. Homogenized 
brain capillary samples were centrifuged at 10,000 g for 
15 min at 4°C, followed by a centrifugation of the 
denucleated supernatants at 100,000 g for 90 min at 
4°C. Pellets (crude brain capillary plasma membranes) 
were resuspended and protein concentrations were 
determined using the Bradford protein assay. Western 
blots were performed using the NuPage™ electro-
phoresis and blotting system from Invitrogen. Blotting 
membranes were incubated overnight with antibody to 
P-gp (C219; MA1-26528, ThermoFisher, 1μg/ml), 
mTOR (ab134903, Abcam, 1μg/ml), GLUT1 (ab652, 
Abcam, 1μg/ml), and β-actin (ab8226 from Abcam, 
1:1000, 1 μg/ml). Proteins were detected using 
SuperSignal® West Pico Chemoluminescent substrate 
(Pierce, Rockford, IL, USA) and protein bands were 
visualized with a BioRad Gel Doc™ XRS imaging 
system. 
 
Blood glucose and ketone bodies measurements 
 
When the mice were sacrificed, blood samples were 
collected in 500 μl lithium heparin 12.5 IU Terumo 
Capiject Capillary blood collection tubes (Vacutainer 
K2 EDTA) to avoid blood coagulation. A total of 1–2 μl 
of blood sample were used to measure blood glucose 
level using a blood glucose meter and a test strip 
(Clarity Plus, Boca Raton, FL, USA). Another 10 μl of 
blood sample was used for ketone bodies level 
measurement using a STAT-Site M (β-Hydro-
xybutyrate) meter and a test strip (Standbio Ketosite 




Statistical analyses were performed using GraphPad 
Prism 6 (GraphPad, San Diego, CA, USA). All data are 
expressed as mean ± SEM. Results were assessed using 
two-way analysis of variance (ANOVA). Tukey’s test 
was further used as a post hoc test to detect between-
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